When more is not better: Treatment intensification among hypertensive patients with poor medication adherence

Circulation

Volumn 117, Issue 22, 2008, Pages 2884-2892

  Heisler, Michele ^a,b,c,f   Hogan, Mary M ^a   Hofer, Timothy P ^a,b,c   Schmittdiel, Julie A ^d   Pladevall, Manel ^e   Kerr, Eve A ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d KAISER PERMANENTE   (United States)

^e HENRY FORD HOSPITAL   (United States)

^f NONE   (United States)

Author keywords

Adherence; Hypertension; Patients; Quality of care; Treatment intensification

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CHILD; FEMALE; HUMAN; HYPERTENSION; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEWBORN; PATIENT CARE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; HUMANS; HYPERTENSION; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; TREATMENT REFUSAL; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 44649190624     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.724104     Document Type: Article

References (39)

1. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002;136:565-574.
2. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342.
3. American Diabetes Association. Clinical practice recommendations 2005. Diabetes Care. 2005;28:S1-S79.
4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2571.
5. Grant RW, Buse JB, Meigs JB. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care. 2005;28:337-442.
6. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS. Clinical inertia. Ann Intern Med. 2001;135:825-834.
7. Berlowitz DR, Ash AS, Glickman M, Friedman RH, Pogach LM, Nelson AL, Wong AT. Developing a quality measure for clinical inertia in diabetes care. Health Serv Res. 2005;40:1836-1853.
8. Asai Y, Heller R, Kajii E. Hypertension control and medication increase in primary care. J Hum Hypertens. 2002;16:313-318.
9. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413-420.
10. Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, Tang S, Pettitt D, Kerr EA, Selby JV. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med. 2006;144:475-484.
11. Stephenson J. Noncompliance may cause half of antihypertensive drug "failures." JAMA. 1999;282:313-314.
12. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
13. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530.
14. Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care. 2002;40:630-639.
15. Heisler M, Smith DM, Hayward RA, Krein SL, Kerr EA. Racial disparities in diabetes care processes, outcomes, and treatment intensity. Med Care. 2003;41:1221-1232.
16. Piette JD, Heisler M. Problems due to medication costs among VA and non-VA patients with chronic illnesses. Am J Manag Care. 2004;10:861-868.
17. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105-116.
18. Christensen DB, Williams B, Goldberg HI, Martin DP, Engelberg R, LoGerfo JP. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care. 1997;35:1164-1170.
19. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11:449-457.
20. Turner BJ, Hecht FM. Improving on a coin toss to predict patient adherence to medications. Ann Intern Med. 2001;134:1004-1006.
21. Miller LG, Liu H, Hays RD, Golin CE, Beck CK, Asch SM, Ma Y, Kaplan AH, Wenger NS. How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med. 2002;17:1-11.
22. Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, Canning C, Platt R. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846-857.
23. Vitolins MZ, Rand CS, Rapp SR, Ribisl PM, Sevick MA. Measuring adherence to behavioral and medical interventions. Control Clin Trials. 2000;21:S188-S194.
24. Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27:2149-2153.
25. Borzecki AM, Wont AT, Hickey EC, Ash AS, Berlowitz DR. Can we use automated data to assess quality of hypertension care? [published correction appears in Am J Manag Care. 2004;10:586] Am J Manag Care. 2004;10:473-479.
26. Kerr EA, Smith DM, Hogan MM, Hofer TP, Krein SL, Bermann M, Hayward RA. Building a better quality measure: are some patients with "poor quality" actually getting good care? Med Care. 2003;41:1173-1182.
27. Cook CB, Ziemer DC, El-Kebbi IM, Gallina DL, Dunbar VG, Ernst KL, Phillips LS. Diabetes in urban African-Americans, XVI: overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care. 1999;22:1494-1500.
28. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004;27:2800-2805.
29. Schultz JS, O'Donnell JC, McDonough KL, Sasane R, Meyer J. Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population. Am J Manag Care. 2005;11:306-312.
30. Smedley BD, Stith AY, Nelson AR. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care: A Report of the Institute of Medicine. Washington, DC: National Academy Press; 2002.
31. Lutfey KE, Wishner WJ. Beyond "compliance" is "adherence": improving the prospect of diabetes care. Diabetes Care. 1999;22:635-639.
32. Schectman JM, Schorling JB, Nadkarni MM, Voss JD. Can prescription refill feedback to physicians improve patient adherence? Am J Med Sci. 2004;327:19-24.
33. Shojania KG, McDonald KM, Nayak S, Owens DK, Lewis R, Sundaram V, Davies SM, Medina A, Goldstein MK, Henne M, Shah B, Chan KJ. Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies, Volume 3: Hypertensive Care. Stanford, Calif: Stanford-UCSF Evidence-Based Practice Center, for the Agency for Healthcare Research and Quality; 2005.
34. Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, Owens DK. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA. 2006;296:427-440.
35. Krousel-Wood M, Morisky D, Hyre A, Muntner P. Methods to improve medication adherence in patients with hypertension: current status and future directions. Curr Opin Cardiol. 2005;20:296-300.
36. Krousel-Wood M, Desalvo K, Re RN, Muntner P, Jannu A. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci. 2005;330:128-133.
37. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimen. J Hypertens. 2004;22:1831-1837.
38. Grant R, Adams AS, Mah Trinacty C, Zhang F, Kleinman K, Soumerai SB, Meigs JB, Ross-Degnan D. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007;30:807-812.
39. Enhancing Prescription Medicine Adherence: A National Action Plan. Bethesda, Md: National Council on Patient Information and Education; 2007.